bioRxiv Science⌕ Search

Biology subjects

Xiao, B.

Publications and source records attributed to Xiao, B..

At least 19 recordsLinked to original sources

Reinforcement learning with evolutionary priors unlocks multi-site enzyme optimization from sparse experimental feedback

Industrial enzymes underpin sustainable manufacturing, yet natural proteins rarely combine the activity, robustness and application compatibility required for practical use. Engineering such properties requires identifying beneficial combinations of interacting mutations within vast sequence spaces that are too large to search exhaustively and too sparsely sampled to model reliably. Here we introduce AlphaVariant, a reinforcement-learning (RL) framework that couples a generative evolutionary prior with iteratively updated low-N fitness models to enable feedback-driven search of large combinatorial protein sequence spaces. Across six experimentally measured protein fitness landscapes, AlphaVariant ranked first on the three large, non-enumerable multi-site landscapes. In two successive rounds of savinase activity optimization, AlphaVariant-designed libraries yielded 75.4% and 83.8% activity-improved variants among experimentally characterized candidates even as the accessible mutation space expanded from 25 to 67 positions. The search identified beneficial mutation combinations involving up to 17 structurally dispersed sites and produced a variant with 7.1-fold higher activity than wild type after only two design-test cycles. We then extended AlphaVariant to jointly optimize activity, thermostability and a patent-informed constraint for intellectual-property freedom. This multi-objective search yielded variants that outperformed the commercial protease Uno 100 L in both biochemical assays and application-relevant detergent washing tests. These results demonstrate that generative RL can efficiently navigate vast protein fitness landscapes, progressively incorporate multiple engineering objectives and convert sparse experimental feedback into enzyme variants with industrially relevant performance, effectively resolving the limits of biocatalyst engineering.

bioinformatics↗

MOLA: a novel topological data analysis framework for analyzing multiomic loops in precision medicine

Multiomic datasets contain complex nonlinear relationships that are often missed by conventional analysis methods. Topological data analysis (TDA) can detect some such patterns (i.e., loops), and here we extend previous TDA approaches with MOLA (MultiOmic Loop Analysis), a framework for multiomic loop visualization, filtering, association with sample-level characteristics and functional characterization. In an Influenza A virus dataset, MOLA better captured anticipated characteristic-dependent epigenetic alterations compared to standard approaches. In a breast cancer cohort, higher loop participation in five genes was associated with increased hazard of progression. MOLA provides an interpretable framework for discovering biologically meaningful multiomic patterns and potential biomarkers.

genomics↗

Structural assemblies for an RNA world

Protein homo-oligomerization widely generates symmetric assemblies for encapsulation and scaffolding. Conversely, natural RNA quaternary structures appear limited, with known RNA-only multimers predominantly forming dimers or dihedral assemblies from long transcripts. Whether short RNAs can access broader higher-order assembly space has remained unclear. Here, using cryo-EM, we show that RNAs under 200 nucleotides form three distinct structural classes: a 60-subunit viral-capsid-like icosahedron, non-caged oligomers including a trimer and a strand-exchanged dimer, and a continuous filament assembled from a 57-nucleotide RNA. These structures demonstrate that assembly complexity does not simply scale with RNA length; compact RNAs can specify architectures traditionally associated with proteins. Our findings broaden the known RNA quaternary repertoire, strengthen the structural plausibility of higher-order organization in an RNA world, and establish foundational reference architectures to guide future RNA-based self-assembling nanoparticle design. HighlightsO_LIShort RNAs reveal protein-like assembly principles for an RNA world C_LIO_LIThe first natural RNA-only T=1 icosahedral cage is a viral-capsid-like 60-mer C_LIO_LICompact RNA-RNA interfaces encode global curvature, valency and propagation C_LIO_LIRNA motifs assemble into closed cages, finite oligomers and extended filaments C_LI

evolutionary biology↗

Reference-guided immune recovery matching prioritizes traditional Chinese medicine ingredients

Screening therapeutic candidates from single-cell transcriptomes requires a target that is closer to treatment response than disease-signature reversal. In immune diseases, post-treatment recovery may follow patient- and lineage-specific trajectories rather than a simple return along the pretreatment disease axis. We developed ImmuneNavi, an artificial intelligence virtual cell (AIVC) immune recovery model for ranking traditional Chinese medicine ingredients from paired PBMC data. The model maps heterogeneous PBMC cohorts to a common healthy immune coordinate system, constructs patient-lineage disease and recovery states, and processes ITCM treated-control profiles into a fixed ingredient perturbation bank. Patient and ingredient states are represented in matched gene, pathway and transcription-factor views, allowing the model to combine local transcriptional direction with more stable program-level features. A matcher trained on one paired treatment cohort preserved recovery-aligned ingredient rankings in independent PBMC cohorts without redefining the feature space, candidate set or preprocessing procedure. ImmuneNavi provides an AIVC model that uses paired immune-state measurements to screen natural-product candidates for experimental follow-up.

bioinformatics↗

From hotspot dependence to distributed robustness in resistance-aware lead optimization

Drug resistance remains a recurrent failure mode in targeted anticancer and antiviral therapy, and resistance evidence often enters only after compound selection. ResistAgent is an evidence-constrained framework that converts mutational liabilities into design-time objectives through site- and combo-aware resistance mapping, deterministic mechanism diagnosis and robust counter-design. In EGFR-Erlotinib and HIV-RT-Rilpivirine, the framework separated residue-level liabilities from observed HIV combination liabilities and linked prioritized mutations to anchor loss, pocket rearrangement, electrostatic shifts and contact redistribution. Same-budget paired searches showed that robust objectives changed lower-tail mutant-panel behavior and interaction-dependence profiles while prioritizing robustness over average-affinity behavior. Under predefined liability panels, robust-objective trajectories shifted support away from mutable hotspot contacts toward more distributed interaction networks. Supplementary physical summaries and ranking-first benchmarks support the validation envelope of this resistance-aware design strategy.

bioinformatics↗

A Sandwich-Structured Silk Fibroin Mesh with ROS-Responsive and Immunoregulatory Functions for Pelvic Floor Repair

Current biodegradable meshes for pelvic floor repair are constrained by a limited ability to actively modulate the hostile immune microenvironment following implantation. To address these challenges, we developed a functionalized degradable silk fibroin mesh (SFM) integrated with a reactive oxygen species (ROS)-responsive nanocomposite hydrogel. The resulting composite mesh, SFM@Gel-NP, features a "hydrogel-mesh-hydrogel" sandwich structure, wherein the hydrogel layers are loaded with self-assembled nanoparticles (NP-H-CRFP) for the co-delivery of the STING inhibitor H-151 and the ROS-scavenging agent catechin. This design provides immediate mechanical reinforcement while enabling microenvironment-triggered drug release. In vitro, NP-H-CRFP demonstrated efficient cellular uptake, significant ROS clearance, and effective attenuation of macrophage inflammation and apoptosis. In vivo, SFM@Gel-NP remodeled the local immune milieu by inhibiting the ROS/cGAS-STING/NF-{kappa}B axis, thereby promoting a shift from pro-inflammatory M1 toward pro-regenerative M2 macrophage polarization. This immunomodulatory effect, coupled with enhanced and well-organized collagen deposition--particularly of early type III collagen--resulted in improved tissue integration and repair. This work presents a novel strategy that combines structural reinforcement with active immune regulation, offering a promising next-generation solution for durable and functional pelvic floor reconstruction.

bioengineering↗

Mouse behavioral genomics identifies Creld1 as a gatekeeper of somatosensation

Somatosensation enables the perception of touch, temperature, pain, and itch. These sensory modalities are mediated by primary sensory neurons in the dorsal root ganglion (DRG), which convert physical and chemical stimuli into electrical signals using specialized molecular sensors, including the touch sensor PIEZO2 (Ref1,2) and temperature sensors such as TRPV1 (Ref3,4), coupled with downstream voltage-gated sodium channels (Nav) like Nav1.7 (Ref5,6). However, the full repertoire of molecular components involved in somatosensory processing remains incompletely identified. Here, we developed an efficient postnatal CRISPR-Cas9 knockout platform to screen DRG-expressed genes via AAV9-sgRNA delivery. Combining this approach with behavioral assays of somatosensory responses, we validated the roles of PIEZO2 and TRPV1 in sensing gentle touch and noxious heat, respectively, and the broad involvement of Nav1.7 in distinct somatosensory modalities. Remarkably, a targeted screen of 20 DRG-expressed genes identified the Cysteine-rich with EGF-like domains 1 (Creld1) as a master regulator of somatosensation. Either sgRNA-mediated postnatal knockout or tamoxifen-induced Cre-mediated deletion of Creld1 in DRG neurons resulted in profound behavioral deficits in touch, temperature, pain, and itch perception, while its overexpression enhanced touch and thermal responses. Mechanistically, Creld1 functions as a novel auxiliary regulator of Nav for controlling the excitability of DRG neurons. The biochemical interaction and functional modulation of Nav by mouse Creld1 are mediated via its C-terminal transmembrane region. Notably, this domain is conserved in mouse Creld1 and some isoforms of human CRELD1, resulting in an isoform-dependent regulation of Nav1.7. Together, this work establishes a robust postnatal screening platform for somatosensory genomics and identifies Creld1 as a master regulator of somatosensory function, and provides novel therapeutic strategy for pain and itch treatment.

neuroscience↗

ProteinMCP: An Agentic AI Framework for Autonomous Protein Engineering

Computational protein design is often constrained by slow, complex, inaccessible, and highly sophiscated and expert-dependent workflows that hinder its transferrability and generalization power for broader applications. We present ProteinMCP, an agentic AI framework designed to accelerate and democratize protein engineering. ProteinMCP automates end-to-end scientific tasks, delivering dramatic gains in efficiency; for instance, a comprehensive protein fitness modeling workflow was completed in just 11 minutes. This performance is achieved by an AI agent that intelligently orchestrates a unified ecosystem of 38 specialized tools, made accessible through a Model-Context-Protocol (MCP). A cornerstone of the framework is an automated pipeline that converts existing software into MCP-compliant servers, ensuring the platform is both powerful and perpetually extensible. We further demonstrate its capabilities through the successful autonomous design and selection of high-affinity de novo binders and therapeutic nanobodies. By removing technical barriers, ProteinMCP has the potential to shorten the design-build-test cycle and make advanced computational protein design accessible to the broader scientific community.

bioinformatics↗

Co-evolution of Oncogenic KRAS Signaling and LILRBhigh Macrophages Drives Pancreatic Cancer Recurrence

Pancreatic ductal adenocarcinoma (PDAC) frequently recurs after surgical resection, indicating that residual disease is sustained by coordinated tumor-microenvironment interactions. To define the biological basis of recurrence, we leverage large-scale clinical data from 2,710 patients, deeply characterized multi-omics profiling (whole-exome, bulk RNA, and single-nucleus sequencing) of 36 matched primary and locally recurrent PDACs, an in-house multiplex spatial imaging cohort of 190 patients, and extensive public datasets. Recurrent tumors were characterized by increased KRAS mutant allele dosage and reinforced KRAS signaling, accompanied by expansion of basal-like malignant cell states. In parallel, we identified an immunosuppressive macrophage population marked by high LILRB expression that spatially co-localized with KRAS-activated tumor cells. Functional studies showed that LILRB4+ macrophages enhanced tumor cell plasticity and progression, whereas inhibition of macrophage LILRB4 suppressed these phenotypes. Notably, a first-in-class human anti-LILRB4 antibody reduced macrophage-driven tumor traits, and dual targeting of KRAS signaling and LILRB4 achieved superior tumor control in macrophage-containing mouse models. These findings reveal a co-evolved tumor-immune niche underlying PDAC recurrence and nominate the KRAS-LILRB4 axis as a therapeutic vulnerability.

cancer biology↗

A vagal gut-brain axis for feeding induced gastric secretion

Feeding begins with food-seeking and ends with nutrient absorption and waste elimination. Although meal-related sensory cues are known to shape feeding behavior, how they engage neural circuits to control digestion remains unclear. We dissected vagal gut-brain-gut pathways that mediate meal-induced gastric secretion. Vagal afferent neurons innervating the stomach were necessary and sufficient for secretion. Among those, Glp1r and Sst neurons robustly drove acid, pepsin, and gastrin secretion, whereas Oxtr and Vip neurons had little effect. Piezo2 was expressed in Glp1r mechanosensory afferents, and conditional deletion of Piezo channels attenuated distension-evoked secretion. On the efferent limb, genetically defined vagal motor neuron subsets differentially recruited secretory outputs: Cck neurons broadly increased acid, pepsin, and gastrin, whereas Grp neurons preferentially drove acid secretion. Finally, enteric circuit dissection revealed modular output control: Calb2 enteric neurons potently drove secretion with minimal motility effects, Grp enteric neurons coupled secretion to motility, and Cysltr2 enteric neurons selectively modulated acid output. Together, these results define a cell-type resolved vagal-enteric architecture for gastric control and show that secretory and motor programs can be segregated across dedicated enteric neuron subtypes.

neuroscience↗

The structure and catalytic mechanism of new cellular and viral HDV ribozymes

We have determined the molecular structure and investigated the catalytic mechanism of two new ribozymes of the Hepatitis delta virus family, found in the nematode Caenorhabditis briggsae and virus Ackermannviridae. Crystal structures of both conform to the double-pseudoknot architecture adopted by the viral HDV ribozyme. The C. briggsae ribozyme has been determined both pre- and post-cleavage. In the former both nucleotides flanking the scissile phosphate are observed, along with a metal ion, and cytosine 75 N3 bound to the O5 leaving group. The pH dependence of cleavage rate reveals a pKa of 6.6 and together with the inactivity of a C75U mutant provides evidence for its role as general acid. In contrast to other nucleolytic ribozymes that use catalytic metal ions, reaction rate does not depend on the pKa of the divalent metal ion. Limited adjustment of structure of the active center is consistent with direct bonding of the metal ion to the O2 and non-bridging O, suggesting that the ion acts as a Lewis acid to activate nucleophilic attack. This mechanism appears to be general for the HDV ribozyme class, and distinguishes it from the majority of nucleolytic ribozymes that use general base catalysis.

biochemistry↗

Organelle biogenesis on a synthetic bead

How cells build their many organelles remains poorly understood. Centrosomes are a striking example: structurally complex organelles built from more than one hundred different proteins. Here we show that a synthetic bead can generate centrosome-like particles (CLiPs) in early Drosophila embryos if it is programmed to recruit any one of five essential centrosome assembly proteins. CLiPs behave remarkably like centrosomes: organising centrosomal proteins, microtubules and actomyosin, forming spindle poles, and undergoing multiple rounds of duplication - all in synchrony with the embryonic cell cycle. The beads generate CLiPs because they recruit Plk4, the master regulator of centrosome biogenesis, in a specific manner that stimulates its assembly activity. Thus, recruiting a single protein to a synthetic surface is sufficient to seed the self-assembly of a complex, self-propagating entity. These findings suggest a general framework for organelle biogenesis in which simple localised molecular inputs can seed the self-assembly of highly complex cellular structures.

cell biology↗

Discovery of potent oligopeptides for various metabolic diseases using deep learning

Artificial intelligence (AI)-based methods are increasingly critical in peptide drug discovery, but their applications are limited in a narrow scope such as antimicrobial peptides. For indications where peptide therapy inherently excels, such as metabolism, endocrinology, and tissue regeneration, AI-based pipeline for therapeutic peptide discovery is long awaited but still unmet. Here, we propose a deep learning-based pipeline, Deepeptide, capable of identifying therapeutic oligopeptides for various metabolism-related indications. Leveraging the intrinsical relationship of disease indication -- biological processes -- molecular functions, Deepeptide discovers oligopeptides with indication-ameliorating-related molecular functions as lead candidates for indication of interest. Deepeptide was applied in five representative indications of metabolism, endocrinology, and tissue regeneration: angiogenesis, lipid metabolism, osteogenesis, glucose metabolism, and anti-angiogenesis. Overall, 62% of the identified oligopeptide candidates demonstrated significant bioactivity in vitro, with most of them showing comparable potency to the first-line drugs. Notably, the heptapeptide AP7 exhibited angiogenic potency comparable to VEGF in excisional wound splinting mouse model by promoting cell migration rather than proliferation, and hexapeptide TP6 showed significant dual-efficacy against hyperlipidemia and obesity in high-fat diet mice by inhibiting lipid synthesis and regulating gut microbiota. These findings highlight the potential and generalizability of Deepeptide in therapeutic oligopeptide discovery for metabolic diseases.

bioinformatics↗

A disease mutation reveals a non-swapped pore and rewired gating cycle of the mechanically activated PIEZO1 channel

PIEZO1 is a versatile mechanotranduction channel critical for diverse cellular and physiological processes1-3. Gain-of-function mutations, such as R2482H, which slow channel inactivation, are linked to dehydrated hereditary stomatocytosis (DHS) and iron overload4-7. PIEZO1 forms a gigantic bowl-shaped trimer comprising flattenable peripheral blades and a central pore module with a switchable cap8-12. However, the structural dynamics governing its gating process and pathogenesis remain incompletely understood. Here, we determined distinct conformational states of the DHS-associated PIEZO1-R2482H mutant in both detergents and proteoliposomes. Remarkably, the R2482H mutation in the central pore induces a conformational change that propagates [~]25 nm to the most distal blade, enabling resolution of all 38 transmembrane helices. PIEZO1-R2482H is inherently flatter than PIEZO1, lowering the gating force and energy barrier and thus explaining its heightened mechanosensitivity. While the flattened PIEZO1 has its cap in the up-state adopting an inactivated state, the flattened PIEZO1-R2482H has its cap in the down-state and twisted by [~]75{degrees}, drastically switching the pore module from a swapped to a non-swapped organization. Such twisted conformation of PIEZO1-R2482H might hinder the transition to the inactivated state, instead proceeding through a deactivation-transition state characterized by curved blades and a partially twisted cap, thereby accounting for the slowed inactivation and deactivation kinetics. Taken together, we reveal the full transmembrane topology and a non-swapped pore conformation induced by R2482H, and propose the structural dynamic model that delineates the distinct gating cycle of activation, inactivation, and deactivation for PIEZO1 and PIEZO1-R2482H.

biophysics↗

Predictive in vitro profiling of LNP-induced innate immune response using an iPSC-derived monocyte model

Lipid nanoparticles (LNPs) are a powerful drug delivery platform advancing vaccines and gene therapies. While their efficacy and safety has been found to be closely linked to innate immune activation, current in vitro models are unable to predict immune responses reliably. Conventional models, such as PBMCs, are limited by donor variability and inconsistent sensitivity. To address this, we developed a cytokine profiling platform using induced pluripotent stem cell (iPSC)-derived monocytes (iMonocytes), a physiologically relevant innate immune cell type that plays a key role in immune surveillance and inflammation. iPSCs provide a renewable, uniform monocyte source for consistent, high-sensitivity LNP screening. When tested with LNPs of graded immunostimulatory potency, iMonocytes showed improved reproducibility and strong correlation with in vivo cytokine responses. This platform enables evaluation of cargo- and dose-dependent effects, providing a robust and scalable tool for preclinical assessment and rational design of LNP therapeutics.

bioengineering↗

Structural Role of Stomatin in Organizing Functional Membrane Microdomains

Stomatin, originally discovered in red blood cells, is a member of the SPFH (Stomatin, Prohibitin, Flotillin, and HflK/C) protein family, which has long been proposed to scaffold functional membrane microdomains (FMMs) enriched in saturated lipids such as cholesterol and sphingomyelin. Stomatin has been reported to associate with a variety of proteins involved in diverse physiological processes, including ion channel regulation, membrane fusion, mechanosensory regulation and vesicle trafficking; however, the mechanisms by which it modulates these interactions remain poorly understood. Here, we determined the cryo-electron microscopy (cryo-EM) structures of stomatin, revealing its hexadecameric assemblies. The SPFH1 domains insert into the cytosolic leaflet of membranes and, together with the N-terminal hairpin, form a potential cholesterol-binding pocket. Liposome reconstitution experiments demonstrated that stomatin self-organizes into clusters, and Spectrum and Polarization Optical Tomography (SPOT) further showed that these clusters enhance membrane lipid order, supporting the proposed role of stomatin in organizing functional membrane microdomains (FMMs). Proteomic mass spectrometry analysis identified numerous stomatin-associated cargo proteins, including solute carrier (SLC) transporters, RAB GTPases, and integrins, suggesting that stomatin regulates solute transport and contributes to vesicle trafficking and cell migration. Together, these findings elucidate the structural and functional roles of stomatin and underscore its potential as a therapeutic target for modulating cancer cell migration and metastasis.

biophysics↗

Effort choices are sensitive to prior learning

Goal directed behaviour requires the integration of learned beliefs about the world with decisions about whether an outcome is worth the effort required to obtain it. Although value learning and effort-based choice are central to motivated behaviour, they are typically examined in isolation. Here we introduce a novel behavioural paradigm that directly links probabilistic associative learning with effortful decision making, for the first time allowing trial by trial assessment of how learned beliefs guide willingness to exert effort. In a large sample of participants (n=252), individuals reliably acquired stimulus-outcome associations but showed substantial variability in learning fidelity. Effort allocation was not determined by objective reward probabilities, but was better predicted by participants subjective beliefs, demonstrating that effortful action depends on internal value representations rather than external contingencies alone. Reward and loss contexts showed asymmetric effects on effort motivation, revealing a valence specific dissociation in belief driven action. Critically, higher levels of anhedonia were associated with reduced willingness to engage in effortful behaviour and a weaker coupling between learned value and action, indicating a disruption in the integration of belief and motivation. Together, these findings identify a mechanistic link between learning and effort expenditure and suggest that motivational impairments in psychiatric symptoms may arise from failures to translate learned value into action.

neuroscience↗

Computational Assessment of Circularization Impact on Saxitoxin G-quadruplex Aptamer Performance

Although high-affinity and high-specificity aptamers can be obtained by SELEX (Systematic Evolution of Ligands by Exponential Enrichment), and have good activity in vitro, their performance in vivo is poor. This is mainly because of the degradation of linear nucleic acids by nucleases in body fluids and the difficulty of maintaining stable 3D structures in complex body fluid environments, which seriously hinders the clinical application of aptamers. This makes circular aptamers, which can resist degradation and are more stable in complex body fluid environments, an attractive option. However, the cyclization process may have a considerable impact on the structure of the original linear aptamer, and blind cyclization may lead to a decrease in its affinity. Here, we developed a new method to guide the cyclization of saxitoxin (STX) aptamers based on molecular computation, and verified the activity of circular aptamers through bioactivity experiments to further verify the authenticity and reliability of our methods. Consistent with the computational analysis, although circularization disrupts the G4 structure, circular aptamer not only has a higher affinity than the linear one but also provides certain protection to mice and greatly prolongs their survival, which proves the accuracy and reliability of the circular structure designed by our computational method. Our findings provide important ideas for better guidance in the design of circular aptamers and demonstrate their great potential in therapeutic applications.

biochemistry↗